Overview of the role of mupirocin
- 30 September 1991
- journal article
- review article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 19, 27-30
- https://doi.org/10.1016/0195-6701(91)90199-i
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infectionsJournal of the American Academy of Dermatology, 1989
- Methicillin-resistant Staphylococcus aureus: report of an outbreak in a London teaching hospitalJournal of Hospital Infection, 1988
- Topical Mupirocin Versus Oral Erythromycin in the Treatment of Primary and Secondary Skin InfectionsInternational Journal of Dermatology, 1987
- LONG-TERM SURVIVAL IN HAEMODIALYSIS PATIENTSThe Lancet, 1987
- Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)—a controlled trialJournal of Antimicrobial Chemotherapy, 1986
- Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureusJournal of Hospital Infection, 1986
- Control of a hospital outbreak of methicillin-resistant Staphylococcus aureus infections: value of an isolation unitJournal of Hospital Infection, 1985
- In-vitro activity of mupirocin (‘pseudomonic acid’) against clinical isolates of Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1985
- Re-emergence of methicillin-resistant staphylococcus aureus causing severe infectionJournal of Infection, 1984
- NASAL CARRIAGE OF GENTAMICIN AND METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS TREATED WITH TOPICAL PSEUDOMONIC ACIDPublished by Elsevier ,1983